216 related articles for article (PubMed ID: 21603867)
1. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
Kanai M; Imaizumi A; Otsuka Y; Sasaki H; Hashiguchi M; Tsujiko K; Matsumoto S; Ishiguro H; Chiba T
Cancer Chemother Pharmacol; 2012 Jan; 69(1):65-70. PubMed ID: 21603867
[TBL] [Abstract][Full Text] [Related]
2. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
[TBL] [Abstract][Full Text] [Related]
3. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
4. Curcumin as a Multifunctional Spice Ingredient against Mental Disorders in Humans: Current Clinical Studies and Bioavailability Concerns.
Spanoudaki M; Papadopoulou SK; Antasouras G; Papadopoulos KA; Psara E; Vorvolakos T; Solovos E; Chrysafi M; Psallas M; Mentzelou M; Ourda D; Giaginis C
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672750
[TBL] [Abstract][Full Text] [Related]
5. Hybrid curcumin compounds: a new strategy for cancer treatment.
Teiten MH; Dicato M; Diederich M
Molecules; 2014 Dec; 19(12):20839-63. PubMed ID: 25514225
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of a lipidic formulation of curcumin in healthy human volunteers.
Pawar YB; Munjal B; Arora S; Karwa M; Kohli G; Paliwal JK; Bansal AK
Pharmaceutics; 2012 Oct; 4(4):517-30. PubMed ID: 24300368
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of oral curcumin.
Garg AX; Moist L; Pannu N; Tobe S; Walsh M; Weir M;
CMAJ; 2019 Apr; 191(15):E428. PubMed ID: 30988047
[No Abstract] [Full Text] [Related]
8. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.
Kanai M; Otsuka Y; Otsuka K; Sato M; Nishimura T; Mori Y; Kawaguchi M; Hatano E; Kodama Y; Matsumoto S; Murakami Y; Imaizumi A; Chiba T; Nishihira J; Shibata H
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1521-30. PubMed ID: 23543271
[TBL] [Abstract][Full Text] [Related]
9. Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.
Sunagawa Y; Hirano S; Katanasaka Y; Miyazaki Y; Funamoto M; Okamura N; Hojo Y; Suzuki H; Doi O; Yokoji T; Morimoto E; Takashi T; Ozawa H; Imaizumi A; Ueno M; Kakeya H; Shimatsu A; Wada H; Hasegawa K; Morimoto T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):37-44. PubMed ID: 25994138
[TBL] [Abstract][Full Text] [Related]
10. Drinkable preparation of Theracurmin exhibits high absorption efficiency--a single-dose, double-blind, 4-way crossover study.
Morimoto T; Sunagawa Y; Katanasaka Y; Hirano S; Namiki M; Watanabe Y; Suzuki H; Doi O; Suzuki K; Yamauchi M; Yokoji T; Miyoshi-Morimoto E; Otsuka Y; Hamada T; Imaizumi A; Nonaka Y; Fuwa T; Teramoto T; Kakeya H; Wada H; Hasegawa K
Biol Pharm Bull; 2013; 36(11):1708-14. PubMed ID: 24189415
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.
Nakagawa Y; Mukai S; Yamada S; Matsuoka M; Tarumi E; Hashimoto T; Tamura C; Imaizumi A; Nishihira J; Nakamura T
J Orthop Sci; 2014 Nov; 19(6):933-9. PubMed ID: 25308211
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of curcumin for patients with pancreatic cancer.
Kanai M
World J Gastroenterol; 2014 Jul; 20(28):9384-91. PubMed ID: 25071333
[TBL] [Abstract][Full Text] [Related]
13. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
Shoba G; Joy D; Joseph T; Majeed M; Rajendran R; Srinivas PS
Planta Med; 1998 May; 64(4):353-6. PubMed ID: 9619120
[TBL] [Abstract][Full Text] [Related]
14. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study.
Khajehdehi P; Zanjaninejad B; Aflaki E; Nazarinia M; Azad F; Malekmakan L; Dehghanzadeh GR
J Ren Nutr; 2012 Jan; 22(1):50-7. PubMed ID: 21742514
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation and pharmacokinetic study of nanoparticle curcumin… by Kanai et al., CCP 69:65-70, 2012.
Gescher AJ
Cancer Chemother Pharmacol; 2012 Sep; 70(3):487. PubMed ID: 22810806
[No Abstract] [Full Text] [Related]
16. Comparative absorption of curcumin formulations.
Jäger R; Lowery RP; Calvanese AV; Joy JM; Purpura M; Wilson JM
Nutr J; 2014 Jan; 13():11. PubMed ID: 24461029
[TBL] [Abstract][Full Text] [Related]
17. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes.
Schiborr C; Kocher A; Behnam D; Jandasek J; Toelstede S; Frank J
Mol Nutr Food Res; 2014 Mar; 58(3):516-27. PubMed ID: 24402825
[TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
[TBL] [Abstract][Full Text] [Related]
19. Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
Kang M; Ho JN; Kook HR; Lee S; Oh JJ; Hong SK; Lee SE; Byun SS
Oncol Rep; 2016 Mar; 35(3):1463-72. PubMed ID: 26718024
[TBL] [Abstract][Full Text] [Related]
20. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.
DiSilvestro RA; Joseph E; Zhao S; Bomser J
Nutr J; 2012 Sep; 11():79. PubMed ID: 23013352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
